$ONTX Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market
NEWTOWN, Pa., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announc...
Find out more ONTX - Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market